Glipizide Tablet, Extended Release
Product Images NDC 70518-3645

3 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 70518-3645). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glipezide Usp (26f0c341 A482 4dc1 Aaef F0a92a84937c 01)

Glipezide Usp (26f0c341 A482 4dc1 Aaef F0a92a84937c 01)
Chemical structure diagram of Glipizide, showing its molecular framework with heterocyclic and aromatic rings and functional groups characteristic to the compound.*
FDA Label Image

Mm1 (Glipizide 2.5mg 70518 3645 00)

Mm1 (Glipizide 2.5mg 70518 3645 00)
Glipizide 2.5 mg extended-release tablet packaging label. Contains 30 tablets. Label includes the NDC number 70518-3645-00 and states the tablets are round and yellow. Repackaged by RemedyRepack Inc., Indiana, PA. Storage instructions recommend keeping the medication out of reach of children and storing at 20-25°C with permitted excursions to 15-30°C.*
FDA Label Image

Mm2 (Glipizide 2.5mg 70518 3645 01)

Mm2 (Glipizide 2.5mg 70518 3645 01)
Glipizide extended-release tablets 2.5 mg, packaged quantity of 90 tablets. The label shows the product name, strength, and dosage form, with a note to see the insert for usual dosage. It is repackaged by RemedyRepack Inc., Indiana, PA, with storage instructions between 20-25°C. The label includes the NDC number 70518-3645-01 and identifies the tablets as round yellow 2.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.